Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Amortization of Deferred Charges (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Amortization of Deferred Charges for 3 consecutive years, with $354000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Amortization of Deferred Charges fell 76.68% to $354000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $2.1 million, a 64.54% decrease, with the full-year FY2024 number at $5.5 million, down 20.13% from a year prior.
  • Amortization of Deferred Charges was $354000.0 for Q3 2025 at SANUWAVE Health, down from $532000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $2.0 million in Q2 2023 to a low of $354000.0 in Q3 2025.
  • A 3-year average of $1.3 million and a median of $1.5 million in 2024 define the central range for Amortization of Deferred Charges.
  • Peak YoY movement for Amortization of Deferred Charges: fell 10.76% in 2024, then crashed 76.68% in 2025.
  • SANUWAVE Health's Amortization of Deferred Charges stood at $1.3 million in 2023, then tumbled by 41.99% to $728000.0 in 2024, then crashed by 51.37% to $354000.0 in 2025.
  • Per Business Quant, the three most recent readings for SNWV's Amortization of Deferred Charges are $354000.0 (Q3 2025), $532000.0 (Q2 2025), and $530000.0 (Q1 2025).